Code
|
8476A
|
MA number
|
EU/1/13/888/001
|
Product Form:
|
plv iol 1x250 IU+4 ml solv.+1 adaptér inj.liek. (liek.inj.skl.+striek.inj.napl.skl.)
|
MA Status:
|
E - Valid centralised marketing authorisation
|
Type of procedure:
|
EU
|
MAH, country:
|
Novo Nordisk A/S, Denmark
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
ATC:
|
B |
BLOOD AND BLOOD FORMING ORGANS |
B02 |
ANTIHEMORRHAGICS |
B02B |
LOCAL HEMOSTATICS, COMBINATIONS |
B02BD |
Blood coagulation factors |
B02BD02 |
Coagulation factor VIII |
|
Shelf life:
|
30 |
Container:
|
glass vial
|
Route of admin.:
|
Intravenous use
|